Company · Ownership research

BridgeBio Pharma, Inc. BBIO

CIK 0001743881

Form 4 transactions dated Sep 1, 2023 to Sep 28, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through 2026-08-20.

Insider purchases & sales

Purchased: $0.00
Sold: $1.03B

Sep 1, 2023 – Aug 20, 2026
Available records · partial months are marked ·

2023, from Sep 1, 20238 of 8 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
2023-12-26	MCCORMICK FRANK Director	Sale10b5-1 footnote	$4.21M 100,000 shares sold	13.74% sold Indirect holding	▾
2023-12-18	Scott Randal W. Director	Sale10b5-1 footnote	$80.00K 2,000 shares sold	18.18% sold Indirect holding	▾
2023-12-15	Valantine Hannah Director	Sale10b5-1 footnote	$105.29K 2,915 shares sold	62.30% sold Direct holding	▾
2023-12-01	Scott Randal W. Director	Sale10b5-1 footnote	$73.50K 2,500 shares sold	18.52% sold Indirect holding	▾
2023-11-17	STEPHENSON BRIAN C Secretary, Treasurer & CFO	Sale10b5-1 footnote	$660.06K 22,685 shares sold	38.19% sold Direct holding	▾
2023-11-17	Kumar Neil CEO and President · Director	Sale10b5-1 footnote	$1.50M 51,552 shares sold	1.06% sold Direct holding	▾
2023-11-15	Valantine Hannah Director	Sale10b5-1 footnote	$87.45K 2,915 shares sold	62.30% sold Direct holding	▾
2023-09-05	Scott Randal W. Director	Sale10b5-1 footnote	$75.00K 2,500 shares sold	15.63% sold Indirect holding	▾

Showing 8 / 8 record groups in 2023. The complete set is available through the API.

BridgeBio Pharma, Inc. · BBIO

Follow the people behind the trades.

Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 8 of 8 purchase / sale groups and 20 of 20 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"BBIO","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.